Journey Medical CorporationJourney Medical CorporationJourney Medical Corporation

Journey Medical Corporation

No trades
See on Supercharts
Market capitalization
‪70.56 M‬USD
−0.23USD
‪−3.85 M‬USD
‪79.18 M‬USD
‪6.65 M‬
Beta (1Y)
0.19

About Journey Medical Corporation

CEO
Claude Maraoui
Headquarters
Scottsdale
Employees (FY)
58
Founded
2014
FIGI
BBG00ZWVDRK2
Journey Medical Corp. is a commercial-stage pharmaceutical company, which focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. Its brands include QBREXZA, Accutane, Targadox, AMZEEQ, Ximino, ZILXI, Exelderm, and Luxamend. The company was founded by Claude Maraoui in October 2014 and is headquartered in Scottsdale, AZ.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of DERM is 3.50 USD — it has decreased by 1.13% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Journey Medical Corporation stocks are traded under the ticker DERM.
Journey Medical Corporation is going to release the next earnings report on May 7, 2024. Keep track of upcoming events with our Earnings Calendar.
DERM stock is 1.72% volatile and has beta coefficient of 0.19. Check out the list of the most volatile stocks — is Journey Medical Corporation there?
DERM earnings for the last quarter are 0.99 USD per share, whereas the estimation was −0.16 USD resulting in a 738.71% surprise. The estimated earnings for the next quarter are −0.09 USD per share. See more details about Journey Medical Corporation earnings.
Journey Medical Corporation revenue for the last quarter amounts to ‪34.50 M‬ USD despite the estimated figure of ‪16.90 M‬ USD. In the next quarter revenue is expected to reach ‪14.95 M‬ USD.
Yes, you can track Journey Medical Corporation financials in yearly and quarterly reports right on TradingView.
DERM stock has fallen by 12.50% compared to the previous week, the last month showed zero change in price, over the last year Journey Medical Corporation has showed a 130.26% increase.
DERM net income for the last quarter is ‪−2.14 M‬ USD, while the quarter before that showed ‪16.79 M‬ USD of net income which accounts for −112.76% change. Track more Journey Medical Corporation financial stats to get the full picture.
Today Journey Medical Corporation has the market capitalization of ‪70.56 M‬, it has increased by 0.46% over the last week.
No, DERM doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, DERM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Journey Medical Corporation stock right from TradingView charts — choose your broker and connect to your account.
DERM reached its all-time high on Nov 12, 2021 with the price of 10.20 USD, and its all-time low was 1.02 USD and was reached on May 18, 2023.
See other stocks reaching their highest and lowest prices.
As of Apr 23, 2024, the company has 58.00 employees. See our rating of the largest employees — is Journey Medical Corporation on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Journey Medical Corporation technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Journey Medical Corporation stock shows the sell signal. See more of Journey Medical Corporation technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Journey Medical Corporation future price: according to them, DERM price has a max estimate of 8.50 USD and a min estimate of 8.00 USD. Read a more detailed Journey Medical Corporation forecast: see what analysts think of Journey Medical Corporation and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Journey Medical Corporation EBITDA is ‪5.43 M‬ USD, and current EBITDA margin is 6.22%. See more stats in Journey Medical Corporation financial statements.